| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 8 Nov 2025 | 3 Nov 2025 |
| Kriti Industries India Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/11/2025 inter alia to consider and approve the following businesses along with other routine businesses: 1. Approval of the Standalone and Consolidated Un-audited Financial Results of the Company for the quarter and half year ended 30th September 2025; 2. To take on Record the Limited Review Report by the Statutory Auditors for the Standalone and Consolidated Un-audited Financial Results of the Company for the quarter and half year ended 30th September 2025; 3. Approval of the Standalone and Consolidated Un-Audited Statement of Assets and Liabilities and Statement of Cash Flow for the half year ended 30th September 2025; 4. Merger and Amalgamation with the Company of KRITI AUTO & ENGINEERING PLASTICS PRIVATE LIMITED Wholly Owned Subsidiary of the Company by way of merger procedure under Chapter XV (Compromise Arrangements and Amalgamations) of the Companies Act 2013 and other relevant provisions of Companies Act and Securities and Exchange Board of India Regulations; Pursuant to Regulation 33 of SEBI (LODR) Regulations,2015, we are enclosing : 1. Unaudited Standalone & Consolidated Financial Results for the Quarter and Half Year ended on 30th September,2025. 2. Limited Review Report by the Statutory Auditors on the Unaudited Standalone & Consolidated Financial Results for the quarter ended on 30th September,2025. The outcome of the said Board Meeting is as follows: 1. Approval of the Unaudited Standalone and Consolidated Financial Results of the Company for the Quarter and Half year ended 30th September, 2025; 2. To take on record the Limited Review Report by the Statutory Auditors for the Unaudited Standalone and Consolidated Financial Results of the Company for the Quarter and Half year ended on 30th September, 2025. 3. Approval of amalgamation of Kriti Auto & Engineering Plastics Private Limited (Wholly owned Subsidiary) with the Company. 4. Other Routine Business Agenda. (As Per BSE Announcement Dated on:08.11.2025) | ||
| Board Meeting | 12 Aug 2025 | 5 Aug 2025 |
| Kriti Industries India Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2025 inter alia to consider and approve 1. Approval of the Un-Audited Standalone & Consolidated Financial Results of the Company for the Quarter ended 30th June 2025; 2. To take on record the Limited Review Report by the Auditors for the Un-Audited Standalone & Consolidated Financial Results of the Company for the Quarter ended 30thJune 2025; 3. And other Routine Businesses. Outcome of the 3/2025-26 Meeting of Board of Directors of the company held on Tuesday, 12th August, 2025 at the Corporate Office of the Company as per Regulation 30 of SEBI (LODR) Regulations, 2015 (As Per BSE Announcement Dated on: 12/08/2025) | ||
| Board Meeting | 12 Jun 2025 | 7 Jun 2025 |
| Kriti Industries India Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/06/2025 inter alia to consider and approve 1. To consider and approve conversion of warrants into the equity shares of the Company subject to depositing the balance outstanding amount for conversion of warrants into the equity shares of the Company; 2. And other general business as may be transacted by the Board. Allotment of 15,92,480 (Fifteen Lakh Ninety-Two Thousand Four Hundred and Eighty only) Equity shares of Re. 1/- each at a premium of Rs.157.50 per share to Kriti Nutrients Limited, warrant holder categorised under the Promoter group of the company (As Per BSE Announcement Dated on :12.06.2025) | ||
| Board Meeting | 22 May 2025 | 15 May 2025 |
| Kriti Industries India Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 22/05/2025 inter alia to consider and approve 452001 to consider and approve inter alia: 1. The Audited Standalone and Consolidated financial results of the Company for the Quarter and Year ended 31st March 2025; 2. The Auditors Report issued by the Statutory Auditors for the Audited Standalone and Consolidated Financial Results of the Company for the Quarter and Year ended 31st March 2025; 3. The Audited Standalone and Consolidated Financial Statements including the Statement of Assets & Liabilities as at 31stMarch 2025 and the Statement of Profit and Loss and Cash Flows Statement of Changes in equity and notes thereon for the financial year ended 31stMarch 2025; 4. Recommendation of final dividend if any for the financial year ending March 31 2025; 5. Any other matter with the permission of the chair. 1. Approval of the Standalone & Consolidated Audited Financial Results for the Quarter & Year ended 31stMarch, 2025; 2. Approval of Auditors Report along with modified/unmodified opinion on the Financial Results for the Quarter & Year ended 31stMarch, 2025; 3. Approval of the Standalone & Consolidated Audited Financial Statements, including the Balance Sheet, as at 31st March, 2025 and the Statement of Profits and Loss and Cash Flow, Statement of Changes in Equity and notes thereon for the year ended 31st March, 2025; 4. Appointment of Mr. Venkat Subramaniam (DIN 00078868) as an Additional Independent Director w.e.f. 22nd May, 2025; 5. Appointment of Ms. Aditi Randhar as the Company Secretary and Compliance Officer w.e.f. 26th May, 2025; 6. The Board has not recommended any dividend on Equity Shares of Re 1/- each for the Financial year 2024-25; 7. Other Routine Business Agendas The Board has not recommended any dividend on Equity Shares of Re 1/- each for the Financial year 2024-25; 1. Approval of the Standalone & Consolidated Audited Financial Results for the Quarter & Year ended 31stMarch, 2025; 2. Approval of Auditors Report along with modified/unmodified opinion on the Financial Results for the Quarter & Year ended 31stMarch, 2025; 3. Approval of the Standalone & Consolidated Audited Financial Statements, including the Balance Sheet, as at 31st March, 2025 and the Statement of Profits and Loss and Cash Flow, Statement of Changes in Equity and notes thereon for the year ended 31st March, 2025; 4. Appointment of Mr. Venkat Subramaniam (DIN 00078868) as an Additional Independent Director w.e.f. 22nd May, 2025; 5. Appointment of Ms. Aditi Randhar as the Company Secretary and Compliance Officer w.e.f. 26th May, 2025; 6. The Board has not recommended any dividend on Equity Shares of Re 1/- each for the Financial year 2024-25; 7. Other Routine Business Agendas . (As Per BSE Announcement Dated on: 22/05/2025) | ||
| Board Meeting | 11 Feb 2025 | 4 Feb 2025 |
| KRITI INDUSTRIES (INDIA) LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/02/2025 inter alia to consider and approve 1. Approval of the UFR for the Quarter and Nine months ended on 31.12.24; 2. take on Record the Limited Review Report; 3. conversion of warrants into the equity shares of the Company subject to depositing the balance outstanding amount for conversion of warrants into the equity shares of the Company; 4. And other general business. Outcome of the 6/2024-25 Meeting of Board of Directors of the company held on Tuesday, 11th February, 2025 at the Corporate Office of the Company as per Regulation 30 of SEBI (LODR) Regulations, 2015 (As Per BSE Announcement Dated on: 11/02/2025) | ||
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.